The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation

This publication has 46 references indexed in Scilit:

• mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS
  Blood, 2010
• Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus
  Clinical and Experimental Immunology, 2010
• Tolerogenic Dendritic Cells: All Present and Correct?
  American Journal of Transplantation, 2010
• CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols
  Journal of Immune Based Therapies and Vaccines, 2010
• Harnessing Human Dendritic Cell Subsets to Design Novel Vaccines
  Annals of the New York Academy of Sciences, 2009
• DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas lpr/lpr mice in vivo
  Arthritis Research & Therapy, 2009
• Tolerogenic Dendritic Cell-Regulatory T-cell Interaction and the Promotion of Transplant Tolerance
  Transplantation, 2009
• Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
  Nature Reviews Immunology, 2004
• The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily
  European Journal of Immunology, 2003
• Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
  Nature Immunology, 2002